Published in Drug Des Devel Ther on February 13, 2014
Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies. Biochem Med (Zagreb) (2015) 0.83
Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine. PLoS One (2015) 0.77
Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes. Drug Des Devel Ther (2015) 0.76
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-Dependent Changes in the Absence of Clinical Nephrotoxicity. Clin Pharmacol Ther (2016) 0.75
National surveillance of emergency department visits for outpatient adverse drug events. JAMA (2006) 6.24
Acute kidney injury. Lancet (2012) 4.90
Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76
Treatment of acute renal failure. Kidney Int (1998) 4.75
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med (2004) 4.50
Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int (2010) 3.78
Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int (2007) 3.23
Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci (2008) 2.98
Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant (2012) 2.59
Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children. Am J Kidney Dis (2010) 2.35
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol (2010) 2.06
Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol (2010) 2.00
A robust approach to reference interval estimation and evaluation. Clin Chem (1998) 1.67
Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat Biotechnol (2010) 1.64
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol (2010) 1.62
Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not? Kidney Int (2010) 1.56
Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem (2009) 1.50
Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol (2011) 1.35
Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. J Pediatr (2011) 1.28
International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem (1988) 1.14
Urine biomarkers predict acute kidney injury in newborns. J Pediatr (2012) 1.11
An appraisal of statistical procedures used in derivation of reference intervals. Clin Chem Lab Med (2010) 1.10
The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients. Dis Markers (2013) 1.06
Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study. Am J Nephrol (2011) 1.03
Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines. J Pharm Biomed Anal (2005) 1.03
Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int (2003) 0.98
Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies. Crit Care Med (2010) 0.97
Creatinine. Curr Opin Crit Care (2010) 0.96
Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. Toxicol Sci (2011) 0.95
A generic operational strategy to qualify translational safety biomarkers. Drug Discov Today (2011) 0.94
Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease. Nephrol Dial Transplant (2002) 0.94
Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Clin Chem Lab Med (2013) 0.92
Renal biomarkers predict nephrotoxicity after paraquat. Toxicol Lett (2013) 0.92
Comparison of urinary biomarkers for early detection of acute kidney injury after cardiopulmonary bypass surgery in infants and young children. Pediatr Cardiol (2012) 0.91
Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences. Toxicol Pathol (2012) 0.90
Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury. Biomarkers (2011) 0.87
Urinary NGAL measurement: biological variation and ratio to creatinine. Clin Chim Acta (2010) 0.87
Early detection of renal damage caused by fumaric acid ester therapy by determination of urinary β2-microglobulin. Br J Dermatol (2011) 0.86
Urinary 28-kD calbindin-D as a new marker for damage to distal renal tubules caused by cisplatin-based chemotherapy. Urol Int (1996) 0.86
Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine. Congenit Heart Dis (2012) 0.83
Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. Br J Nutr (2010) 0.82
Analytical and biological validation of a multiplex immunoassay for acute kidney injury biomarkers. Clin Chim Acta (2012) 0.81
Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic Acid. Toxicol Pathol (2012) 0.79
Clinically silent progressive renal tubulointerstitial disease during cisplatin chemotherapy. Cancer (1993) 0.79
Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate. Antimicrob Agents Chemother (2005) 0.78
Assessment of biomarkers of drug-induced kidney injury in cynomolgus monkeys treated with a triple reuptake inhibitor. Toxicol Sci (2011) 0.76